Products & Services
Digital health solution, Simoa, is changing the way in which the biology of health and disease is studied by giving researchers the ability to closely examine critical biomarkers. In doing so, Quanterix enables development of methods providing much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for applications in a majority of therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease.
SIMOA HD-X ANALYZER™
Delivering Ultrasensitive Biomarker Measurement You Can Count On.
The latest model is a fully automated Simoa bead-based immunoassay platform. HD-X delivers major productivity improvements, greater user flexibility,
unparalleled sensitivity, and best-in-class assay performance across a broad assay menu to empower biomarker research and accelerate drug development.